Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study

Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study

Abstract Background Antiretrovirals, including tenofovir, can suppress human immunodeficiency virus (HIV) infection but cannot completely eradicate it. Patients with HIV infection are administered antiretroviral drugs over a long term; thus, managing consequent adverse drug reactions, such as renal...

Full description

Bibliographic Details
Main Authors: Mahoko Ikeda, Yoshitaka Wakabayashi, Koh Okamoto, Shintaro Yanagimoto, Shu Okugawa, Kyoji Moriya
Format: Article
Language:English
Published: BMC 2021-05-01
Series:AIDS Research and Therapy
Subjects:
HIV-infection
Antiretrovirals
Biomarkers
Tenofovir disoproxil fumarate
Tenofovir alafenamide
Online Access:https://doi.org/10.1186/s12981-021-00354-y

Internet

https://doi.org/10.1186/s12981-021-00354-y

Similar Items